Advances in immunotherapy of M2 macrophages and gastrointestinal stromal tumor

doi:10.4251/wjgo.v16.i7.2915

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (476)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

HTML

346

Figures (1-5)

Sum=417

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=39

Jul 15, 2024 (publication date) through Aug 13, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Jul 15, 2024; 16(7): 2915-2924
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.2915

Full Size Figure Download Figure

Figure 5 Inhibiting the generation of M2 tumor-associated macrophages is important for tumor progression. GIST: Gastrointestinal stromal tumor; IFN: Interferon; IL: Interleukin; PD-1/PD-L1: Programmed death receptor-1/programmed death ligand-1; TGF: Transforming growth factor.

Citation: Wang XK, Yang X, Yao TH, Tao PX, Jia GJ, Sun DX, Yi L, Gu YH. Advances in immunotherapy of M2 macrophages and gastrointestinal stromal tumor. World J Gastrointest Oncol 2024; 16(7): 2915-2924
URL: https://www.wjgnet.com/1948-5204/full/v16/i7/2915.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.2915